The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Siemens Medical Solutions USA, Inc. provides medical products and solutions. It offers imaging systems, therapy equipment, and hearing instruments for diagnosis, treatments, and patient monitoring. The firm services include imaging and therapy, customer resources and logins, healthcare financing solutions and laboratory diagnostics services. The company was founded in 1896 and is headquartered in Malvern, PA.

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

The Istituto Superiore di Sanità (Italian National Institute of Health), also ISS, is an Italian public institution that, as the leading technical-scientific body of the Italian National Health Service (Servizio Sanitario Nazionale), performs research, trials, control, counseling, documentation and training for public health. The Institute is under the supervision of the Ministero della Salute (Ministry of Health).

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Venture Creations Incubator is a RIT sponsored company that allows young companies to advance their concepts to become a viable business.

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Siemens AG is a technology company, which engages in the areas of automation and digitalization in the process and manufacturing industries, infrastructure for buildings and energy systems, mobility solutions for rail transport, and medical technology and digital healthcare services. It operates through the following segments: Digital Industries, Smart Infrastructure, Mobility, Siemens Healthineers, and Siemens Financial Services. The Digital Industries segment offers a product portfolio and system solutions for automation used in discrete and process industries. The Smart Infrastructure segment includes products, systems, solutions, services and software to support a transition from fossil to renewable energy sources. The Mobility segment combines all Siemens businesses in the area of passenger and freight transportation. The Siemens Healthineers segment develops, manufactures, and sells diagnostic and therapeutic products, and services to healthcare providers. The Siemens Financial Services segment focuses on financing solutions for Siemens’ customers as well as other companies in the form of debt and equity investments. The company was founded by Johann Georg Halske and Werner von Siemens on October 12, 1847 and is headquartered in Munich, Germany.

Fujian Ruining Information Technology Co., Ltd., established on 2015-08-31, Business scope includes information system integration services;Information Technology Consulting Services;Construction engineering labor subcontracting;Communication Engineering,Building Intelligent Engineering,Safety Technology Prevention Engineering,Lightning protection project,Cable TV Engineering,Electronic Engineering,Steel structure engineering,Urban landscaping project,Design of Building Decoration Project,construction,maintain;electronic,communication,Radio and television technical services(The above business scope does not include the installation of ground receiving facilities for satellite TV broadcasting);computer information technology,software development,Sales;Multimedia equipment installation,Sales;Electronic equipment,household appliances,Office Supplies,communication device,Sales of computer software, hardware and accessories,repair;Logistics distribution,delivery service;Warehousing,carry,Loading and unloading service;forest tending;flowers,seedlings,seedling planting,Sales(The above business scope does not contain dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Merck KGaA, Merck & Cie KG is a company headquartered in Altdorf, Switzerland, that provides pharmaceutical preparation services.

Yantai Lannacheng Biotechnology Co., Ltd., established on 2021-01-06, Business scope includes licensed projects:Drug Clinical Trial Services;pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;marketing planning;Import and export;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Xinbo Medical Technology Co., Ltd., established on 2011-06-02, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Machinery sales;electronics sales;Home Appliance Sales;Instrument sales;Retailing of computer software, hardware and auxiliary equipment;Instrument Repair;General Equipment Repair;Special Equipment Repair;electrical equipment repair;Communication equipment repair;Import and export;Technology Import and Export;Import and export agency;Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.

Taiwan Hopax Chemicals Manufacturing Co., Ltd. engages in the manufacture, processing and trading of chemical products. Its products include papermaking chemicals, water treatment chemicals, image display chemicals, fine chemicals, biological cleaning agents, biological buffer agents, alkyl sulfonic acid intermediates, electroplate additives, lithium battery additives as well as office stationery products, including pastel notes, self-adhesive notes and re-stick tapes. The company was founded on February 7, 1975 and is headquartered in Kaohsiung, Taiwan.

EPIX Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics through the use of its proprietary silico drug discovery technology to treat diseases of the central nervous system and lung conditions. Its therapeutic product candidates in development PRX-08066, a small-molecule inhibitor that completed Phase II clinical trials for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with chronic obstructive pulmonary disease; and PRX-07034, which completed Phase I studies for the treatment of cognitive impairment associated with schizophrenia. The company also offers Vasovist, an injectable intravascular contrast agent to provide enhanced imaging of the vascular system using magnetic resonance angiography. It has collaborations with SmithKline Beecham Corporation, Amgen Inc., and Cystic Fibrosis Foundation Therapeutics, Incorporated. The company was formerly known as EPIX Medical, Inc. and changed its name to EPIX Pharmaceuticals, Inc. in 2004. EPIX Pharmaceuticals, Inc. was founded in 1988 and is based in Lexington, Massachusetts. As of July 20, 2009, EPIX Pharmaceuticals, Inc. is in liquidation.

Shanghai Ergonomics Detecting Instrument Co., Ltd., a subsidiary of Tianjin Jieqiang Power Equipment Co., Ltd., is a company headquartered in Shanghai, China, involved in measuring and controlling devices. The firm was founded in 2008. Zhi Yong Zhang is the current CEO of the company. Shanghai Ergonomics Detecting Instrument Co., Ltd. was acquired by Tianjin Jieqiang Power Equipment Co., Ltd. from Anji Yige Enterprise Management Partnership LP on September 08, 2021 for $26.95 million.